SERODIAGNOSIS BY PASSIVE HEMAGGLUTINATION TEST AND VEROTOXIN ENZYME-LINKED-IMMUNOSORBENT-ASSAY OF TOXIN-PRODUCING ESCHERICHIA-COLI INFECTIONS IN PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME

被引:19
作者
YAMADA, S
KAI, A
KUDOH, Y
机构
关键词
D O I
10.1128/JCM.32.4.955-959.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Eight cases of hemolytic-uremic syndrome in which no pathogens were isolated were diagnosed serologically by a passive hemagglutination assay and a verotoxin (VT; Shiga-like toxin) enzyme-linked immunosorbent assay (ELISA). The passive hemagglutination assay employed formalinized sheep erythrocytes sensitized with soluble native antigen or heat-treated antigen (lipopolysaccharide [LPS]) from Escherichia coli 026, 0111, 0128, and O157 or flagellar antigen of nine different H serogroups of E. coli: H2, H7, H8, H10, H11, H12, H18, H19, and H25. All patients had antibodies against the native antigen and/or the LPS of E. coli O157, but positive agglutination with H7 was observed only in one patient. In the VT-ELISA with plates coated with purified VT 1 or VT 2, antibody against VT 2 was observed in the sera of five of six patients examined, but none of the patients possessed VT 1 antibody. These results indicate that the causative pathogen in these eight hemolytic-uremic syndrome cases is likely to be VT-producing E. coli O157. The passive hemagglutination assay described here is a very sensitive, simple, and rapid method. This assay is highly recommended for the serological diagnosis of VT-producing E. coli infections, particularly in patients infected by serogroup O157 strains. Furthermore, the VT-ELISA is useful in studying the role of VT in hemolytic-uremic syndrome.
引用
收藏
页码:955 / 959
页数:5
相关论文
共 23 条
[1]   INDIRECT HEMAGGLUTINATION ASSAY FOR DIAGNOSIS OF ESCHERICHIA-COLI O157 INFECTION IN PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME [J].
BITZAN, M ;
KARCH, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) :1174-1178
[2]   DIFFERENCES IN VEROTOXIN NEUTRALIZING ACTIVITY OF THERAPEUTIC IMMUNOGLOBULINS AND SERA FROM HEALTHY CONTROLS [J].
BITZAN, M ;
KLEMT, M ;
STEFFENS, R ;
MULLERWIEFEL, DE .
INFECTION, 1993, 21 (03) :140-145
[3]   SERUM ANTIBODIES TO ESCHERICHIA-COLI SEROTYPE O157-H7 IN PATIENTS WITH HEMOLYTIC UREMIC SYNDROME [J].
CHART, H ;
SCOTLAND, SM ;
ROWE, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (02) :285-290
[4]   SEROLOGICAL IDENTIFICATION OF ESCHERICHIA-COLI O157-H7 INFECTION IN HEMOLYTIC UREMIC SYNDROME [J].
CHART, H ;
SMITH, HR ;
SCOTLAND, SM ;
ROWE, B ;
MILFORD, DV ;
TAYLOR, CM .
LANCET, 1991, 337 (8734) :138-140
[6]   DISSOCIATION OF HUMAN SERUM MACROGLOBULINS [J].
DEUTSCH, HF ;
MORTON, JI .
SCIENCE, 1957, 125 (3248) :600-601
[7]  
HISATUNE K, 1992, 28TH P JOINT C US JA, P106
[8]   METHOD FOR THE ISOLATION OF HIGHLY PURIFIED SALMONELLA FLAGELLINS [J].
IBRAHIM, GF ;
FLEET, GH ;
LYONS, MJ ;
WALKER, RA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (06) :1040-1044
[9]   THE ASSOCIATION BETWEEN IDIOPATHIC HEMOLYTIC UREMIC SYNDROME AND INFECTION BY VEROTOXIN-PRODUCING ESCHERICHIA-COLI [J].
KARMALI, MA ;
PETRIC, M ;
LIM, C ;
FLEMING, PC ;
ARBUS, GS ;
LIOR, H .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (05) :775-782
[10]   INFECTION BY VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI [J].
KARMALI, MA .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (01) :15-38